Wells Fargo Maintains Equal-Weight on Incyte, Lowers Price Target to $62
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Derek Archila has maintained an Equal-Weight rating on Incyte (NASDAQ:INCY) but has lowered the price target from $63 to $62.
October 10, 2024 | 3:22 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Wells Fargo has maintained its Equal-Weight rating on Incyte but reduced the price target from $63 to $62, indicating a slightly less optimistic outlook.
The lowering of the price target by Wells Fargo suggests a slightly less optimistic view on Incyte's stock performance, which could lead to a minor negative impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100